Sylvie Brégigeon

677 total citations
24 papers, 216 citations indexed

About

Sylvie Brégigeon is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Sylvie Brégigeon has authored 24 papers receiving a total of 216 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 10 papers in Epidemiology and 9 papers in Virology. Recurrent topics in Sylvie Brégigeon's work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (9 papers) and HIV/AIDS Research and Interventions (7 papers). Sylvie Brégigeon is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (9 papers) and HIV/AIDS Research and Interventions (7 papers). Sylvie Brégigeon collaborates with scholars based in France, Martinique and Sweden. Sylvie Brégigeon's co-authors include Isabelle Poizot‐Martin, Olivia Zaegel‐Faucher, Veronique Obry‐Roguet, Caroline Solas, Bruno Lacarelle, Carla E. Cano, Vincent Pradel, Catherine Tamalet, Isabelle Ravaux and C. Lions and has published in prestigious journals such as Blood, AIDS and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Sylvie Brégigeon

22 papers receiving 214 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Brégigeon France 9 133 95 69 58 34 24 216
Cristina Mussini Italy 11 154 1.2× 210 2.2× 131 1.9× 77 1.3× 47 1.4× 15 366
Staci M. Lockhart United States 11 186 1.4× 43 0.5× 90 1.3× 57 1.0× 7 0.2× 13 307
Luigi Pusterla Italy 7 245 1.8× 144 1.5× 138 2.0× 92 1.6× 7 0.2× 8 366
Sara Bañón Spain 11 152 1.1× 150 1.6× 87 1.3× 62 1.1× 12 0.4× 24 308
JM Miró Spain 8 199 1.5× 84 0.9× 118 1.7× 135 2.3× 14 0.4× 14 355
Veronique Obry‐Roguet France 8 118 0.9× 74 0.8× 67 1.0× 72 1.2× 11 0.3× 12 211
Livia Giner Spain 8 81 0.6× 71 0.7× 69 1.0× 77 1.3× 23 0.7× 13 191
Ricky Hsu United States 9 161 1.2× 92 1.0× 85 1.2× 64 1.1× 8 0.2× 20 255
Wadzanai Samaneka United States 10 111 0.8× 60 0.6× 28 0.4× 66 1.1× 19 0.6× 21 204
Anja Potthoff Germany 10 69 0.5× 150 1.6× 37 0.5× 72 1.2× 18 0.5× 24 249

Countries citing papers authored by Sylvie Brégigeon

Since Specialization
Citations

This map shows the geographic impact of Sylvie Brégigeon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Brégigeon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Brégigeon more than expected).

Fields of papers citing papers by Sylvie Brégigeon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Brégigeon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Brégigeon. The network helps show where Sylvie Brégigeon may publish in the future.

Co-authorship network of co-authors of Sylvie Brégigeon

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Brégigeon. A scholar is included among the top collaborators of Sylvie Brégigeon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Brégigeon. Sylvie Brégigeon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Legrand, Faézeh, Olivia Zaegel‐Faucher, Sylvie Brégigeon, et al.. (2022). Feasibility of Cellular Therapies in HIV Infected Patients: A Monocentric Retrospective Analysis. Blood. 140(Supplement 1). 12959–12960.
2.
Lê, Minh, Naïm Bouazza, Florence Gattacceca, et al.. (2020). Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV‐infected patients. British Journal of Clinical Pharmacology. 86(12). 2404–2413. 9 indexed citations
3.
Gantner, Pierre, Clotilde Allavena, Claudine Duvivier, et al.. (2020). Post‐exposure prophylaxis completion and condom use in the context of potential sexual exposure to HIV*. HIV Medicine. 21(7). 463–469. 4 indexed citations
4.
Poizot‐Martin, Isabelle, Claudine Duvivier, C. Lions, et al.. (2020). Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015. Journal of the European Academy of Dermatology and Venereology. 34(5). 1065–1073. 5 indexed citations
5.
Solas, Caroline, Naïm Bouazza, Minh Lê, et al.. (2019). Concentration–response model of rilpivirine in a cohort of HIV-1-infected naive and pre-treated patients. Journal of Antimicrobial Chemotherapy. 74(7). 1992–2002. 9 indexed citations
6.
Martin, A., et al.. (2019). Dépistage des IST en pratique courante : à chaque âge son IST !. Médecine et Maladies Infectieuses. 49(4). S89–S89. 1 indexed citations
7.
Lions, C., Olivia Zaegel‐Faucher, Sylvie Brégigeon, et al.. (2019). Hepatitis C virus-microelimination program and patient trajectories after hepatitis C virus cure in an outpatient HIV clinical unit. European Journal of Gastroenterology & Hepatology. 32(9). 1212–1221. 2 indexed citations
8.
Obry‐Roguet, Veronique, Sylvie Brégigeon, Carla E. Cano, et al.. (2018). Risk factors associated with overweight and obesity in HIV-infected people. Medicine. 97(23). e10956–e10956. 34 indexed citations
9.
Petit, Nathalie, P. Enel, Isabelle Ravaux, et al.. (2018). Frail and pre-frail phenotype is associated with pain in older HIV-infected patients. Medicine. 97(6). e9852–e9852. 17 indexed citations
10.
Poizot‐Martin, Isabelle, et al.. (2018). HIV infection and care pathway: From guidelines to clinical practice. Médecine et Maladies Infectieuses. 49(1). 23–33. 1 indexed citations
11.
Gattacceca, Florence, Minh Lê, Yazdan Yazdanpanah, et al.. (2018). Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine. European Journal of Clinical Pharmacology. 74(4). 473–481. 7 indexed citations
12.
13.
Solas, Caroline, Sylvie Brégigeon, Sylvie Quaranta, et al.. (2017). Ledipasvir and tenofovir drug interaction in human immunodeficiency virus–hepatitis C virus coinfected patients: Impact on tenofovir trough concentrations and renal safety. British Journal of Clinical Pharmacology. 84(2). 404–409. 7 indexed citations
14.
Brégigeon, Sylvie, et al.. (2017). Frailty in HIV infected people. AIDS. 31(11). 1573–1577. 15 indexed citations
15.
Brégigeon, Sylvie, Caroline Solas, Olivia Zaegel‐Faucher, et al.. (2016). Impact of Tenofovir dose Adjustment on Both Estimated Glomerular Filtration Rate and Tenofovir trough Concentration. Antiviral Therapy. 22(6). 529–533. 3 indexed citations
16.
Poizot‐Martin, Isabelle, Sylvie Brégigeon, Catherine Tamalet, et al.. (2016). A Case of Undiagnosed HIV Infection in a 57-Year-Old Woman with Multiple Myeloma: Consequences on Chemotherapy Efficiency and Safety. Case Reports in Oncological Medicine. 2016. 1–4. 1 indexed citations
17.
Tamalet, Catherine, Isabelle Ravaux, Jacques Moreau, et al.. (2015). Emergence of clusters of CRF02_AG and B human immunodeficiency viral strains among men having sex with men exhibiting HIV primary infection in southeastern France. Journal of Medical Virology. 87(8). 1327–1333. 11 indexed citations
18.
Zaegel‐Faucher, Olivia, Sylvie Brégigeon, Carla E. Cano, et al.. (2015). Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy. AIDS. 29(12). 1505–1510. 16 indexed citations
19.
Cloarec, Nicolas, Olivia Zaegel‐Faucher, Sylvie Brégigeon, et al.. (2014). Mandibular osteonecrosis and dental exfoliation after trigeminal zoster in an HIV-infected patient. AIDS. 28(3). 448–450. 8 indexed citations
20.
Poizot‐Martin, Isabelle, Caroline Solas, Veronique Obry‐Roguet, et al.. (2012). Renal Impairment in Patients Receiving a Tenofovir-cART Regimen. JAIDS Journal of Acquired Immune Deficiency Syndromes. 62(4). 375–380. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Mussini Breakdown of academic impact, for papers by Staci M. Lockhart Breakdown of academic impact, for papers by Luigi Pusterla Breakdown of academic impact, for papers by Sara Bañón Breakdown of academic impact, for papers by JM Miró Breakdown of academic impact, for papers by Veronique Obry‐Roguet Breakdown of academic impact, for papers by Livia Giner Breakdown of academic impact, for papers by Ricky Hsu Breakdown of academic impact, for papers by Wadzanai Samaneka Breakdown of academic impact, for papers by Anja Potthoff
Rankless by CCL
2026